no hope for doleraine - 4th hole a dud

the mxr presentation for the agm, indicated that the 4th hole was a dud (nsa - ie no significant assays). . 3 out of 4 holes were duds - and that must seriously downgrade doleraine.

there was no extra news about selheim - so that is probably still draining funds. the company mentions that it had about $750,000 in cash at the end of october. at the end of september, the company had about $700,000 - but subsequent to the end of the quarter, the company received a rebate of $332,000 - - so it seems that most of the $332,000 has been spent.